Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses

Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses

US Patent 12285480 · Granted Apr 29, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Training and implementing a steady state log analyzer2025
Rapid verification of virus particle production for a personalized vaccine2025
SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucle2025
Detecting systemwide service issues by using anomaly localization2025
Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid 2024
Genetically modified non-human animals and methods relating to complement depend2023
Rapid verification of virus particle production for a personalized vaccine2023
Methods and compositions for combination immunotherapy2022
Combination immunotherapies comprising IL-15 superagonists2022
Methods and compositions for combination immunotherapy2021
Compositions and methods for alphavirus vaccination2021
Combination immunotherapies comprising IL-15 superagonists2021